Edication Pricing News Today

Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare...

Reducing out-of-pocket costs in a value-based medication plan may modestly improve short-term health outcomes in commercially insured individuals with diabetes.

The monthly price of Ozempic went up 3.5% to almost $970, while the cost of Mounjaro rose 4.5% to almost $1070 a month, according to a new report in The Wall Street Journal.

Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed...

The Biden Administration has announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.

Programs that offer financial assistance and transportation as well as grants that help cover expenses are among the key strategies that can help reduce the financial stress of breast cancer care.

Swiss drugmaker Novartis said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine Entresto.

Amazon.com said on Tuesday its online pharmacy will automatically apply manufacturer-sponsored coupons to more than 15 insulin and diabetes medicines.

Baby Ben Kutschke was diagnosed at 3 months with spinal muscular atrophy, a rare inherited disorder which is the leading genetic cause of death in infancy globally.

Drugmakers are bracing for the US governments announcement of the 10 prescription medicines that will be subject to the first-ever price negotiations by the Medicare health program.